• No se han encontrado resultados

Doble antiagregacin plaquetaria en pacientes con infarto agudo de miocardio con elevacin del segmento ST y tratamiento tromboltico

N/A
N/A
Protected

Academic year: 2020

Share "Doble antiagregacin plaquetaria en pacientes con infarto agudo de miocardio con elevacin del segmento ST y tratamiento tromboltico"

Copied!
20
0
0

Texto completo

Loading

Figure

Tabla 2. Distribución de pacientes según factores por grupos de estudio.
Gráfico 1. Distribución de pacientes según localización del infarto y presencia de complicaciones   por grupos de estudio
Tabla 4. Distribución de pacientes, según complicaciones por grupos de estudio y localización del infarto
Table 2. Distribution of patients according to factors by study groups.
+3

Referencias

Documento similar

Conclusiones: en el quinquenio estudiado, disminuyó gradualmente el total de pacientes con diagnóstico de síndrome coronario agudo, y la letalidad por esta causa, en la

Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study

One trial evaluated maintenance therapy with certolizumab pegol versus placebo after response to induction with certolizumab, finding that 36% of patients in the treatment

Thus, a physiotherapy program based on manual therapy may be safe in patients with hemophilia and inhibitor and such therapy may improve joint condition, pain, and joint range of

Patients with ST-segment-elevation myocardial infarction receiving primary percutaneous coronary intervention (PPCI) within 6 hours of symptoms were randomized to

Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment-Elevation Myocardial Infarction: The MIMI Study...

We think that the next statement is also questionable: “Prolonged new convex ST-segment elevation, particularly when associated with reciprocal ST-segment depression, usually

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of